Literature DB >> 10757975

Neurofibrillary tangle-associated collapsin response mediator protein-2 (CRMP-2) is highly phosphorylated on Thr-509, Ser-518, and Ser-522.

Y Gu1, N Hamajima, Y Ihara.   

Abstract

3F4, a monoclonal antibody raised against partially purified paired helical filaments (PHFs), strongly labeled neurofibrillary tangles and some plaque neurites but barely labeled neuropil threads. The levels of the 65-kDa antigen were significantly increased in the soluble fraction of the brains affected by Alzheimer's disease (AD), as compared with that in the case of control brains. The antigen was previously identified as human collapsin response mediator protein-2 (hCRMP-2) by sequencing the immunoaffinity-purified 65-kDa antigen [Yoshida, H., Watanabe, A., and Ihara, Y. (1998) J. Biol. Chem. 273, 9761-9768]. Here, we show that the 3F4 antigen represents a highly phosphorylated form of CRMP-2. The 3F4-reactive phosphoepitope was localized to the carboxyl-terminal portion of hCRMP-2, and was created by a novel 45-50-kDa protein kinase in rat brain extract. Site-directed mutagenesis of this portion showed that multiple sites of CRMP-2 are differentially phosphorylated within residues 507-522, and that phosphorylation of three sites, Thr-509, Ser-518, and Ser-522, is required for full 3F4 binding. The phosphorylation of this particular portion carboxyl-terminal to the basic region of CRMP-2 may play an important role in regulating its activity, and may be involved in the formation of degenerating neurites in AD brain.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10757975     DOI: 10.1021/bi992323h

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  58 in total

Review 1.  Collapsin response mediator protein-2: an emerging pathologic feature and therapeutic target for neurodisease indications.

Authors:  Kenneth Hensley; Kalina Venkova; Alexandar Christov; William Gunning; Joshua Park
Journal:  Mol Neurobiol       Date:  2011-01-28       Impact factor: 5.590

Review 2.  Collapsin response mediator proteins regulate neuronal development and plasticity by switching their phosphorylation status.

Authors:  Naoya Yamashita; Yoshio Goshima
Journal:  Mol Neurobiol       Date:  2012-02-18       Impact factor: 5.590

3.  Collapsin response mediator proteins (CRMPs) are a new class of microtubule-associated protein (MAP) that selectively interacts with assembled microtubules via a taxol-sensitive binding interaction.

Authors:  Pao-Chun Lin; Perry M Chan; Christine Hall; Ed Manser
Journal:  J Biol Chem       Date:  2011-09-27       Impact factor: 5.157

4.  Divergent functions through alternative splicing: the Drosophila CRMP gene in pyrimidine metabolism, brain, and behavior.

Authors:  Deanna H Morris; Josh Dubnau; Jae H Park; John M Rawls
Journal:  Genetics       Date:  2012-05-29       Impact factor: 4.562

5.  Involvement of WAVE accumulation in Abeta/APP pathology-dependent tangle modification in Alzheimer's disease.

Authors:  Kazuyuki Takata; Yoshihisa Kitamura; Yukinori Nakata; Yasuji Matsuoka; Hidekazu Tomimoto; Takashi Taniguchi; Shun Shimohama
Journal:  Am J Pathol       Date:  2009-06-04       Impact factor: 4.307

6.  A derivative of the CRMP2 binding compound lanthionine ketimine provides neuroprotection in a mouse model of cerebral ischemia.

Authors:  Shadia E Nada; Jatin Tulsulkar; Aparna Raghavan; Kenneth Hensley; Zahoor A Shah
Journal:  Neurochem Int       Date:  2012-10-02       Impact factor: 3.921

7.  Alpha2-chimaerin, cyclin-dependent Kinase 5/p35, and its target collapsin response mediator protein-2 are essential components in semaphorin 3A-induced growth-cone collapse.

Authors:  Matthew Brown; Tom Jacobs; Britta Eickholt; Giovanna Ferrari; Mabel Teo; Clinton Monfries; Robert Z Qi; Thomas Leung; Louis Lim; Christine Hall
Journal:  J Neurosci       Date:  2004-10-13       Impact factor: 6.167

8.  Neuronal microRNA deregulation in response to Alzheimer's disease amyloid-beta.

Authors:  Nicole Schonrock; Yazi D Ke; David Humphreys; Matthias Staufenbiel; Lars M Ittner; Thomas Preiss; Jürgen Götz
Journal:  PLoS One       Date:  2010-06-11       Impact factor: 3.240

9.  Identification and structural analysis of C-terminally truncated collapsin response mediator protein-2 in a murine model of prion diseases.

Authors:  Fumiko Shinkai-Ouchi; Yoshio Yamakawa; Hideyuki Hara; Minoru Tobiume; Masahiro Nishijima; Kentaro Hanada; Ken'ichi Hagiwara
Journal:  Proteome Sci       Date:  2010-10-20       Impact factor: 2.480

10.  Insight into the role of CRMP2 (collapsin response mediator protein 2) in T lymphocyte migration: the particular context of virus infection.

Authors:  Pascale Giraudon; Adeline Nicolle; Sylvie Cavagna; Claire Benetollo; Romain Marignier; Michel Varrin-Doyer
Journal:  Cell Adh Migr       Date:  2012-10-17       Impact factor: 3.405

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.